{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:46:14Z","timestamp":1760575574468,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.7759\/cureus.94634","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:15:32Z","timestamp":1760534132000},"source":"Crossref","is-referenced-by-count":0,"title":["Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report"],"prefix":"10.7759","author":[{"given":"Eichi","family":"Kakizaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Akao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young NS","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018, 379:1643-56. 10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22184","article-title":"Common features of megakaryocytes and hematopoietic stem cells: What's the connection?","volume":"107","author":"Huang H","year":"2009","unstructured":"Huang H, Cantor AB. Common features of megakaryocytes and hematopoietic stem cells: What's the connection?. J Cell Biochem. 2009, 107:857-64. 10.1002\/jcb.22184","journal-title":"J Cell Biochem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17190","article-title":"Efficacy and safety of romiplostim in refractory aplastic anaemia: A Phase II\/III, multicentre, open-label study","volume":"192","author":"Jang JH","year":"2021","unstructured":"Jang JH, Tomiyama Y, Miyazaki K, et al.. Efficacy and safety of romiplostim in refractory aplastic anaemia: A Phase II\/III, multicentre, open-label study. Br J Haematol. 2021, 192:190-9. 10.1111\/bjh.17190","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002891","article-title":"Romiplostim for treatment of children and young adults with severe aplastic anemia and myelodysplastic syndrome","volume":"46","author":"Sharathkumar A","year":"2024","unstructured":"Sharathkumar A, Carr J, Claassen D, et al.. Romiplostim for treatment of children and young adults with severe aplastic anemia and myelodysplastic syndrome. J Pediatr Hematol Oncol. 2024, 46:252-61. 10.1097\/MPH.0000000000002891","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6063-20","article-title":"Eltrombopag in combination with rabbit anti-thymocyte globulin\/cyclosporine A in immunosuppressive therapy-na\u00efve patients with aplastic anemia in Japan","volume":"60","author":"Imada K","year":"2021","unstructured":"Imada K, Obara N, Iida H, et al.. Eltrombopag in combination with rabbit anti-thymocyte globulin\/cyclosporine A in immunosuppressive therapy-na\u00efve patients with aplastic anemia in Japan. Intern Med. 2021, 60:1159-68. 10.2169\/internalmedicine.6063-20","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes MJ","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, et al.. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012, 367:11-9. 10.1056\/NEJMoa1200931","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour R","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al.. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022, 386:11-23. 10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley DM","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, et al.. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017, 376:1540-50. 10.1056\/NEJMoa1613878","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02683-1","article-title":"Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy","volume":"110","author":"Yamazaki H","year":"2019","unstructured":"Yamazaki H, Ohta K, Iida H, et al.. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy. Int J Hematol. 2019, 110:187-96. 10.1007\/s12185-019-02683-1","journal-title":"Int J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0950-6","article-title":"High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag","volume":"35","author":"Hosokawa K","year":"2021","unstructured":"Hosokawa K, Yamazaki H, Tanabe M, Imi T, Sugimori N, Nakao S. High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag. Leukemia. 2021, 35:906-9. 10.1038\/s41375-020-0950-6","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02971-1","article-title":"Romiplostim is effective for eltrombopag-refractory aplastic anemia: Results of a retrospective study","volume":"112","author":"Ise M","year":"2020","unstructured":"Ise M, Iizuka H, Kamoda Y, Hirao M, Kida M, Usuki K. Romiplostim is effective for eltrombopag-refractory aplastic anemia: Results of a retrospective study. Int J Hematol. 2020, 112:787-94. 10.1007\/s12185-020-02971-1","journal-title":"Int J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20206","article-title":"Romiplostim with ciclosporin A in patients with aplastic anaemia na\u00efve to immunosuppressive therapy: A phase 2\/3 study","volume":"207","author":"Lee JW","year":"2025","unstructured":"Lee JW, Jang JH, Chiba S, et al.. Romiplostim with ciclosporin A in patients with aplastic anaemia na\u00efve to immunosuppressive therapy: A phase 2\/3 study. Br J Haematol. 2025, 207:582-90. 10.1111\/bjh.20206","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014855","article-title":"Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia","author":"Lee JW","year":"2025","unstructured":"Lee JW, Jang JH, Yamazaki H, et al.. Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood Adv. 2025, 10.1182\/bloodadvances.2024014855","journal-title":"Blood Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06337-7","article-title":"Predictive factors of romiplostim response in patients with refractory aplastic anemia: Data from two clinical trials","volume":"104","author":"Jang JH","year":"2025","unstructured":"Jang JH, Mitani K, Tomiyama Y, et al.. Predictive factors of romiplostim response in patients with refractory aplastic anemia: Data from two clinical trials. Ann Hematol. 2025, 104:4003-11. 10.1007\/s00277-025-06337-7","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg P","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011, 365:430-8. 10.1056\/NEJMoa1103975","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241901","article-title":"Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group","volume":"324","author":"Frickhofen N","year":"1991","unstructured":"Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al.. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991, 324:1297-304. 10.1056\/NEJM199105093241901","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","article-title":"Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia","volume":"85","author":"Rosenfeld SJ","year":"1995","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995, 85:3058-65.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00587","article-title":"Pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment","volume":"8","author":"Medinger M","year":"2018","unstructured":"Medinger M, Drexler B, Lengerke C, Passweg J. Pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment. Front Oncol. 2018, 8:587. 10.3389\/fonc.2018.00587","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000478","article-title":"Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag","volume":"133","author":"Winkler T","year":"2019","unstructured":"Winkler T, Fan X, Cooper J, et al.. Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag. Blood. 2019, 133:2575-85. 10.1182\/blood.2019000478","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.457","article-title":"A brief, but comprehensive, guide to clonal evolution in aplastic anemia","volume":"2018","author":"Babushok DV","year":"2018","unstructured":"Babushok DV. A brief, but comprehensive, guide to clonal evolution in aplastic anemia. Hematology Am Soc Hematol Educ Program. 2018, 2018:457-66. 10.1182\/asheducation-2018.1.457","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423362-early-and-long-lasting-hematologic-recovery-in-a-young-adult-with-severe-aplastic-anemia-treated-with-romiplostim-horse-anti-thymocyte-globulin-atg-and-cyclosporine-a-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:15:33Z","timestamp":1760534133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423362-early-and-long-lasting-hematologic-recovery-in-a-young-adult-with-severe-aplastic-anemia-treated-with-romiplostim-horse-anti-thymocyte-globulin-atg-and-cyclosporine-a-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.94634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}